RxElite, Inc.

RxElite, Inc.

RXEI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$11.65K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RxElite, Inc.RxElite, Inc.0--208%-0.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$11,654.00
Enterprise Value$6.03 Million
Earnings per Share$-0.27
Beta6.4
Outstanding Shares116,536,380

Return

Return on Equity-207.77%ROE
Return on Assets-88.51%
Return on Invested Capital-1.32%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.58
Enterprise Value to EBIT-21.51
Enterprise Value to Net Income-1
Total Debt to Enterprise1.22
Debt to Equity0.52Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About RxElite, Inc.

47 employees
CEO: Richard Tener

RxElite, Inc. is a pharmaceutical company that specializes in the development, production, and commercialization of generic prescription drugs, particularly within specialty markets. Its diverse product portfolio encompasses Sterile Liqu...